Year: 2013
Type: article
Study design: Observational Study
Abstract: palliation and long term survival respectively.Survival analysis was undertaken with Kaplan-Meier analyses (Mantel-cox).Results: 160 patients were identified (median age 74.5; male:female 1.8:1).Primary site colonic in 56, rectal in 104 and metastases in 102.Overall median survival was 50 weeks.71 patients had palliative chemotherapy.Palliative R2 resections were undertaken in 29 patients and 62 patients defunctioned.69 patients had no surgical intervention.Absence of metastasis did not confer a significant survival benefit (p¼0.1) while chemotherapy significantly improved survival (p¼0.001).Palliative resection significantly improved survival compared to defunctioning and non-surgical management (p¼0.05);and conferred a significant survival benefit compared to defunctioning alone (p¼0.036).Conclusions: Chemotherapy significantly improved survival.Distant metastasis did not alter prognosis.In patients managed surgically, R2 resection conferred a significant survival advantage and should be considered in all palliative patients with advanced disease when appropriate.
Source: International Journal of Surgery
Institution: North Cheshire and Mersey NHS Foundation Trust
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2324847331
